Selected research
Industry Research
Vitamin and Derivative Industry Research Report 2026
Market perspective
The global Vitamin and Derivative market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Vitamin and Derivative is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Vitamin and Derivative is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Vitamin and Derivative include Lonza Group, Pfizer, Bayer, ParkAcre Enterprises, Nutrilo, DuPont, DSM, BASF and Amway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Vitamin and Derivative market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vitamin and Derivative Market by Company
Lonza Group
Pfizer
Bayer
ParkAcre Enterprises
Nutrilo
DuPont
DSM
BASF
Amway
Aland Nutraceutical
AIE Pharmaceuticals
Adisseo France S.A.A
Vitamin and Derivative Segment by Type
Vitamin and Derivative Capsules
Vitamin and Derivative Powder
Vitamin and Derivative Tablets
Vitamin and Derivative Segment by Application
Pharmaceuticals
Food and Beverages
Dietary Supplements
Personal Care
Others
Vitamin and Derivative Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin and Derivative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin and Derivative and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin and Derivative.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vitamin and Derivative manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vitamin and Derivative by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vitamin and Derivative in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamin and Derivative Capsules
- Vitamin and Derivative Powder
- Vitamin and Derivative Tablets
Applications
- Pharmaceuticals
- Food and Beverages
- Dietary Supplements
- Personal Care
- Others
Companies covered
- Lonza Group
- Pfizer
- Bayer
- ParkAcre Enterprises
- Nutrilo
- DuPont
- DSM
- BASF
- Amway
- Aland Nutraceutical
- AIE Pharmaceuticals
- Adisseo France S.A.A
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vitamin and Derivative Market Size (2021-2032)
- 2.2.2 Global Vitamin and Derivative Sales (2021-2032)
- 2.2.3 Global Vitamin and Derivative Market Average Price (2021-2032)
- 2.3 Vitamin and Derivative by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vitamin and Derivative Capsules
- 2.3.3 Vitamin and Derivative Powder
- 2.3.4 Vitamin and Derivative Tablets
- 2.4 Vitamin and Derivative by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Food and Beverages
- 2.4.4 Dietary Supplements
- 2.4.5 Personal Care
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vitamin and Derivative Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vitamin and Derivative Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Vitamin and Derivative Revenue of Manufacturers (2021-2026)
- 3.4 Global Vitamin and Derivative Average Price by Manufacturers (2021-2026)
- 3.5 Global Vitamin and Derivative Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vitamin and Derivative, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vitamin and Derivative, Product Type & Application
- 3.8 Global Manufacturers of Vitamin and Derivative, Established Date
- 3.9 Global Vitamin and Derivative Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lonza Group
- 4.1.1 Lonza Group Company Information
- 4.1.2 Lonza Group Business Overview
- 4.1.3 Lonza Group Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lonza Group Vitamin and Derivative Product Portfolio
- 4.1.5 Lonza Group Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Vitamin and Derivative Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Bayer
- 4.3.1 Bayer Company Information
- 4.3.2 Bayer Business Overview
- 4.3.3 Bayer Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer Vitamin and Derivative Product Portfolio
- 4.3.5 Bayer Recent Developments
- 4.4 ParkAcre Enterprises
- 4.4.1 ParkAcre Enterprises Company Information
- 4.4.2 ParkAcre Enterprises Business Overview
- 4.4.3 ParkAcre Enterprises Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ParkAcre Enterprises Vitamin and Derivative Product Portfolio
- 4.4.5 ParkAcre Enterprises Recent Developments
- 4.5 Nutrilo
- 4.5.1 Nutrilo Company Information
- 4.5.2 Nutrilo Business Overview
- 4.5.3 Nutrilo Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nutrilo Vitamin and Derivative Product Portfolio
- 4.5.5 Nutrilo Recent Developments
- 4.6 DuPont
- 4.6.1 DuPont Company Information
- 4.6.2 DuPont Business Overview
- 4.6.3 DuPont Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 DuPont Vitamin and Derivative Product Portfolio
- 4.6.5 DuPont Recent Developments
- 4.7 DSM
- 4.7.1 DSM Company Information
- 4.7.2 DSM Business Overview
- 4.7.3 DSM Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 DSM Vitamin and Derivative Product Portfolio
- 4.7.5 DSM Recent Developments
- 4.8 BASF
- 4.8.1 BASF Company Information
- 4.8.2 BASF Business Overview
- 4.8.3 BASF Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BASF Vitamin and Derivative Product Portfolio
- 4.8.5 BASF Recent Developments
- 4.9 Amway
- 4.9.1 Amway Company Information
- 4.9.2 Amway Business Overview
- 4.9.3 Amway Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Amway Vitamin and Derivative Product Portfolio
- 4.9.5 Amway Recent Developments
- 4.10 Aland Nutraceutical
- 4.10.1 Aland Nutraceutical Company Information
- 4.10.2 Aland Nutraceutical Business Overview
- 4.10.3 Aland Nutraceutical Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aland Nutraceutical Vitamin and Derivative Product Portfolio
- 4.10.5 Aland Nutraceutical Recent Developments
- 4.11 AIE Pharmaceuticals
- 4.11.1 AIE Pharmaceuticals Company Information
- 4.11.2 AIE Pharmaceuticals Business Overview
- 4.11.3 AIE Pharmaceuticals Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 AIE Pharmaceuticals Vitamin and Derivative Product Portfolio
- 4.11.5 AIE Pharmaceuticals Recent Developments
- 4.12 Adisseo France S.A.A
- 4.12.1 Adisseo France S.A.A Company Information
- 4.12.2 Adisseo France S.A.A Business Overview
- 4.12.3 Adisseo France S.A.A Vitamin and Derivative Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Adisseo France S.A.A Vitamin and Derivative Product Portfolio
- 4.12.5 Adisseo France S.A.A Recent Developments
5 Global Vitamin and Derivative Market Scenario by Region
- 5.1 Global Vitamin and Derivative Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vitamin and Derivative Sales by Region: 2021-2032
- 5.2.1 Global Vitamin and Derivative Sales by Region: 2021-2026
- 5.2.2 Global Vitamin and Derivative Sales by Region: 2027-2032
- 5.3 Global Vitamin and Derivative Revenue by Region: 2021-2032
- 5.3.1 Global Vitamin and Derivative Revenue by Region: 2021-2026
- 5.3.2 Global Vitamin and Derivative Revenue by Region: 2027-2032
- 5.4 North America Vitamin and Derivative Market Facts & Figures by Country
- 5.4.1 North America Vitamin and Derivative Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vitamin and Derivative Sales by Country (2021-2032)
- 5.4.3 North America Vitamin and Derivative Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Vitamin and Derivative Market Facts & Figures by Country
- 5.5.1 Europe Vitamin and Derivative Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vitamin and Derivative Sales by Country (2021-2032)
- 5.5.3 Europe Vitamin and Derivative Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Vitamin and Derivative Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vitamin and Derivative Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vitamin and Derivative Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vitamin and Derivative Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vitamin and Derivative Market Facts & Figures by Country
- 5.7.1 South America Vitamin and Derivative Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vitamin and Derivative Sales by Country (2021-2032)
- 5.7.3 South America Vitamin and Derivative Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Vitamin and Derivative Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vitamin and Derivative Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vitamin and Derivative Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vitamin and Derivative Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Vitamin and Derivative Sales by Type (2021-2032)
- 6.1.1 Global Vitamin and Derivative Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Vitamin and Derivative Sales Market Share by Type (2021-2032)
- 6.2 Global Vitamin and Derivative Revenue by Type (2021-2032)
- 6.2.1 Global Vitamin and Derivative Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vitamin and Derivative Revenue Market Share by Type (2021-2032)
- 6.3 Global Vitamin and Derivative Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vitamin and Derivative Sales by Application (2021-2032)
- 7.1.1 Global Vitamin and Derivative Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Vitamin and Derivative Sales Market Share by Application (2021-2032)
- 7.2 Global Vitamin and Derivative Revenue by Application (2021-2032)
- 7.2.1 Global Vitamin and Derivative Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vitamin and Derivative Revenue Market Share by Application (2021-2032)
- 7.3 Global Vitamin and Derivative Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vitamin and Derivative Value Chain Analysis
- 8.1.1 Vitamin and Derivative Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vitamin and Derivative Production Mode & Process
- 8.2 Vitamin and Derivative Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vitamin and Derivative Distributors
- 8.2.3 Vitamin and Derivative Customers
9 Global Vitamin and Derivative Analyzing Market Dynamics
- 9.1 Vitamin and Derivative Industry Trends
- 9.2 Vitamin and Derivative Industry Drivers
- 9.3 Vitamin and Derivative Industry Opportunities and Challenges
- 9.4 Vitamin and Derivative Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst